Phase 3 PALOMA-2 trial: I’m excited to... - SHARE Metastatic ...

SHARE Metastatic Breast Cancer

6,597 members8,135 posts

Phase 3 PALOMA-2 trial

daf10 profile image
9 Replies

I’m excited to share with you that the results from the Phase 3 PALOMA-2 trial of IBRANCE® (palbociclib) have been published in The New England Journal of Medicine. To view the Pfizer press release, click here.

pfizer.com/news/press-relea...

These data, presented at the 52nd American Society of Clinical Oncology (ASCO) Annual Meeting in June, further demonstrate the clinical benefit of IBRANCE® (palbociclib) as initial therapy for postmenopausal women with estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+, HER2-) metastatic breast cancer. The PALOMA-2 study showed the combination of IBRANCE and letrozole (Femara) extended progression-free survival (PFS), or the amount of time before tumor growth, by more than 10 months compared with letrozole plus placebo. Further, the study demonstrated that the median PFS of the IBRANCE and letrozole combination exceeded two years – making it the first and only treatment for this population of women to do so in a randomized Phase 3 study.1

Written by
daf10 profile image
daf10
To view profiles and participate in discussions please or .
Read more about...
9 Replies
marlayne profile image
marlayne

After 3 mos. on Ibrance and Femara my original tumor shrunk by 1/2 (as per the PET/CT scan). After 6 mos the cancer cells are not active. I am thrilled.

Tm7777 profile image
Tm7777 in reply to marlayne

Awesome!!!

daf10 profile image
daf10

Fantastic news Glad to hear it I believe that others in this community will benefit from hearing your story

marlayne profile image
marlayne in reply to daf10

Thank you.

Ibelong profile image
Ibelong

Yes, thank you. That validates why my oncologist has not given up on the drug. Seems that he is fighting for me. We have only had one 3 month follow up since I began letrozole and Ibrance. That scan did not conclusively indicate any shrinkage or stabilization to the bone mets. My next pet/ct will be December. I am looking for better news then.

daf10 profile image
daf10 in reply to Ibelong

Crossing my fingers for you Here's hoping for great scans.

fmlyhm0 profile image
fmlyhm0

I am on ibrance with exemestane and so far very little side effects.

Meadesmith profile image
Meadesmith

Thanks, this mirrors my experience. 19 months in, tumor shrinking, bone Mets gone.

DDIL1 profile image
DDIL1

This is an old post but checking to see how long Ibrance and Letrozole has worked for you and others?

You may also like...

Check Out the Latest on Keytruda Late Stage Phase 3 Trial Data!

their drug Keytruda is at the end stages of their phase 3 trials and is a \\"smashing\\" success...

Phase 3 - Emerald Study

several questions I have now signed up for Phase 3 of the Emerald Study. You can look this up on...

Waiting on clinical trial - currently on no treatment

waiting scans & further tests etc to hopefully participate in the Emerald clinical study. Since...

Palbociclib and Overall Survival

With First-Line Palbociclib Plus Letrozole vs Placebo Plus Letrozole in Women With ER+/HER2−...

Info on clinical trial with \"Oral Faslodex/Fulvestrant\"?

response on Ibrance/Letrozole, my wife has seen some progression--so yesterday, she began a new...